{"database": "lobbying", "table": "lobbying_activities", "rows": [[1412866, "b5afc4e5-1fab-4fe9-9733-9f258baa528f", "Q2", "KNIGHT CAPITOL CONSULTANTS", 40036301, "GENZYME CORPORATION", 2013, "second_quarter", "PHA", "Adequate funding for programs of the Food and Drug Administration, including implementation of the Prescription Drug User Fee Act (FY 2014 appropriations for the FDA, H.R. 2410/S. 1244).  Assess potential impact of sequestration on public health/food and drug programs (FY 2014 appropriations for HHS, S. 1284).", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2013-07-18T13:19:22.280000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1412866"], "units": {}, "query_ms": 60.97245099954307, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}